[Angioneurotic Edema of the Head and Neck in Association with ACE Inhibitors]

Overview

Journal HNO

Specialty Otorhinolaryngology

Date 2007 Mar 3

PMID 17333046

Authors

L Wahbe

H-J Schultz-Coulon

Affiliations

Soon will be listed here.

Abstract

Background: ACE-inhibitors are said to cause angioneurotic edema. In spite of the fact that patients with acute angioedema of the head and neck region are usually admitted to an ENT department, there is only limited information available in the otorhinolaryngological literature on the frequency, risk of recurrent episodes and clinical significance of ACE inhibitor related angioedema.

Material And Methods: The medical histories of all patients admitted to our hospital due to acute angioneurotic edema during the period from 1 January 1988 to 31 December 2001 were reviewed. These were supplemented with the results of a standardized questionnaire filed out by the affected patients and of a non-affected control-group.

Results: During the observation period. 121 patients were treated for acute angioneurotic edema of the head and neck region. In 34 patients (=28.1%), edema was related to permanent treatment with ACE inhibitors. The overall frequency of angioedema and the percentage of ACE inhibitor related angioedema showed a continuous increase during the study period. There was a latency from the beginning of ACE inhibitor treatment until the first manifestation of angioedema of up to 13 years. In comparison with the group of edema patients without ACE inhibitor treatment, we found a threefold risk of recurrent edema in the ACE group. Women were affected by recurrent episodes more often than men. Until now, any individual assessment of the probable risk of developing an angioneurotic edema during ACE inhibitor treatment appears to be impossible.

References

Dean D, Schultz D, Powers R . Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci. 2001; 46(5):1239-43. View

Brown N, Ray W, Snowden M, Griffin M . Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996; 60(1):8-13. DOI: 10.1016/S0009-9236(96)90161-7. View

Cosentino M, Leoni O, Michielotto D, Punginelli M, Lecchini S, Frigo G . Increased reporting of adverse reactions to ACE inhibitors associated with limitations to drug reimbursement for angiotensin-II receptor antagonists. Eur J Clin Pharmacol. 2001; 57(6-7):509-12. DOI: 10.1007/s002280100336. View

Chiu A, Newkirk K, Davidson B, Burningham A, Krowiak E, Deeb Z . Angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter review and an algorithm for airway management. Ann Otol Rhinol Laryngol. 2001; 110(9):834-40. DOI: 10.1177/000348940111000906. View

Chiu A, Krowiak E, Deeb Z . Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology. Laryngoscope. 2002; 111(10):1729-31. DOI: 10.1097/00005537-200110000-00011. View

Irons B, Kumar A . Valsartan-induced angioedema. Ann Pharmacother. 2003; 37(7-8):1024-7. DOI: 10.1345/aph.1C520. View

LANDERMAN N, WEBSTER M, Becker E, RATCLIFFE H . Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein. J Allergy. 1962; 33:330-41. DOI: 10.1016/0021-8707(62)90032-1. View

Abdi R, Dong V, Lee C, Ntoso K . Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema. Pharmacotherapy. 2002; 22(9):1173-5. DOI: 10.1592/phco.22.13.1173.33517. View

Bas M, Hoffmann T, Bier H, Kojda G . Increased C-reactive protein in ACE-inhibitor-induced angioedema. Br J Clin Pharmacol. 2005; 59(2):233-8. PMC: 1884750. DOI: 10.1111/j.1365-2125.2004.02268.x. View

10.

AGOSTONI A, Cicardi M . Drug-induced angioedema without urticaria. Drug Saf. 2001; 24(8):599-606. DOI: 10.2165/00002018-200124080-00004. View

11.

Wenzel U, Roben T, Schwietzer G, Stahl R . [The treatment of arterial hypertension. An inquiry among doctors in general practice]. Dtsch Med Wochenschr. 2001; 126(51-52):1454-9. DOI: 10.1055/s-2001-19216. View

12.

Cicardi M, Conciato L, AGOSTONI A . Angioedema due to angiotensin-converting enzyme inhibition: an association frequently unrecognized. Ann Ital Med Int. 1997; 12(1):8-10. View

13.

Ulmer J, Garvey M . Fatal angioedema associated with lisinopril. Ann Pharmacother. 1992; 26(10):1245-6. DOI: 10.1177/106002809202601012. View

14.

Schroder T, Sachse F, Rudack C . [Is tracheotomy of angioedema associated with ACE-inhibitor therapy?]. HNO. 2004; 53(5):459-61. DOI: 10.1007/s00106-004-1107-z. View

15.

LeFebvre J, Murphey L, Hartert T, Jiao Shan R, Simmons W, Brown N . Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension. 2002; 39(2 Pt 2):460-4. DOI: 10.1161/hy0202.103054. View

16.

Bielory L, Lee S, Holland C, Jaker M . Long-acting ACE inhibitor-induced angioedema. Allergy Proc. 1992; 13(2):85-7. DOI: 10.2500/108854192778878845. View

17.

Gabb G, Ryan P, Wing L, Hutchinson K . Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med. 1996; 26(6):777-82. DOI: 10.1111/j.1445-5994.1996.tb00624.x. View

18.

Giannoccaro P, Wallace G, Higginson L, Williams W . Fatal angioedema associated with enalapril. Can J Cardiol. 1989; 5(7):335-6. View

19.

Gibbs C, Lip G, Beevers D . Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol. 1999; 48(6):861-5. PMC: 2014308. DOI: 10.1046/j.1365-2125.1999.00093.x. View

20.

Wernze H . [ACE inhibitor-induced angioedema: remarkable new perspectives for intensive care/emergency medicine]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1998; 33(10):637-41. DOI: 10.1055/s-2007-994824. View